By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Tesaro, Inc. (TSRO) To Announce Second-Quarter 2014 Financial Results On July 24, 2014 7/11/2014 6:00:37 AM
Tesaro, Inc. (TSRO) Summarizes Phase 3 Rolapitant Data Presented At The 2014 American Society of Clinical Oncology Annual Meeting And Provides An Update On Niraparib Development Strategy 6/2/2014 9:51:47 AM
Tesaro, Inc. (TSRO) Appoints Tim Pearson As Chief Financial Officer 5/28/2014 9:01:46 AM
Tesaro, Inc. (TSRO) Announces Webcast Of Investor & Analyst Briefing at American Society of Clinical Oncology 5/27/2014 9:29:15 AM
Tesaro, Inc. (TSRO) Announces Election Of Earl M. (Duke) Collier, Jr. To Board Of Directors And Results Of Annual Stockholder Meeting 5/16/2014 9:26:32 AM
Tesaro, Inc. (TSRO) To Present At The UBS 2014 Global Healthcare Conference 5/14/2014 11:48:56 AM
Tesaro, Inc. (TSRO) Announces Successful Achievement Of Primary And All Secondary Endpoints In Third And Final Phase 3 Trial Of Rolapitant 5/12/2014 6:21:09 AM
Tesaro, Inc. (TSRO) To Present At The Deutsche Bank (DB) Securities 39th Annual Health Care Conference 5/1/2014 9:11:22 AM
Tesaro, Inc. (TSRO) Announces First-Quarter 2014 Operating Results 4/30/2014 5:12:59 PM
Tesaro, Inc. (TSRO) To Announce First Quarter 2014 Financial Results On April 30, 2014 4/17/2014 9:30:20 AM